Autres langues Cannara Biotech Inc.

Actions

LOVE

CA13765U2002

Marché Fermé - Toronto S.E. Autres places de cotation 21:43:05 10/05/2024			Varia. 5j.	Varia. 1 janv.
0,78 ^CAD	0,00 %		+2,63 %	-6,02 %

29/04	Cannara Biotech devient négatif en annonçant une perte nette plus importante au T2 par rapport à l'année précédente, malgré un chiffre d'affaires en hausse de 51 %.	MT
29/04	Cannara Biotech Inc. publie ses résultats pour le deuxième trimestre et le semestre clos le 29 février 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cannara Biotech Turns Negative As Reports Wider Q2 Net Loss Vs a Year Ago, Despite Revenue up 51%	29/04
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	29/04
Cannara Biotech Reports Q2 2024 Financial Results	29/04
Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans	08/02
Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	29/01
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023	11/12
Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	07/12
Cannara Biotech's Fiscal Q4 Profit, Revenue Grows; Up 9.4%	07/12
Cannara Biotech Inc. Reports Earnings Results for the Fourth Quarter Ended August 31, 2023	07/12
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	27/07/23
Cannara Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	27/07/23
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million	27/07/23
Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII	23/05/23
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	24/04/23
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	24/04/23
Cannara Biotech Down Near 8% As Enters into an Automatic Share Purchase Plan	28/02/23
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan	28/02/23
Cannara biotech inc. Announces results of annual shareholder meeting and conversion into equity of a $5m convertible debenture at $0.18 cent per common share	13/02/23
Cannara Biotech Converts CA$5 Million Debenture, Plus Interest, into Nearly 30 Million Shares for Olymbec Investments	10/02/23
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	23/01/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cannara Biotech Inc.

Actions

LOVE

CA13765U2002

Autres langues

Filtres